Allergy/Imm Medical News about preeclampsia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Re-evaluation of the role of STOX1 transcription factor in placental development and preeclampsia
Journal of Reproductive Immunology, 07/10/09

Rigourd V et al. - The current literature is analyzed to evaluate the possible involvement of STOX1 in the pathogenesis of this disease. While preeclampsia obviously cannot be considered as a disease caused by mutation in a single gene, authors argue that STOX1 may be at the center of common pathways leading to preeclampsia.

<< Previous
Total and allergen-specific IgE levels during and after pregnancy...

Next >>
Differential contribution of CDKAL1 variants to psoriasis,...

The Role of Nitric Oxide Synthase Inhibition by Asymmetric Dimethylarginine in the Pathophysiology of Preeclampsia
Gynecologic and Obstetric Investigation, 10/14/09 Relevance Score: 89%

Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype
Journal of Hypertension, 10/05/09 Relevance Score: 88%

The Changes of Plasma Malondialdehyde, Nitric Oxide, and Adrenomedullin Levels in Patients with Preeclampsia
Hypertension in Pregnancy, 10/30/09 Relevance Score: 87%

Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers
Journal of Hypertension, 10/23/09 Relevance Score: 87%

Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia
Archives of Gynecology and Obstetrics, 10/09/09 Relevance Score: 87%